The present investigation was undertaken to explore the antitumor-promoting activity of Aloe vera on 2-stage skin carcinogenesis, induced by a single topical application of 7,12-dimethylbenz(a)anthracene and promoted by treatment of croton oil for 16 weeks in Swiss albino mice. Oral administration of aloe leaf extract at a dose of 1000 mg/kg body weight/d and aloe gel treatment at a dose of 1 mL/ 9 cm 2 /mice/d was found to be effective in decreasing the number and size of the papillomas. A significant reduction in tumor incidence (40.00 ± ± 5.10, 30.00 ± ± 3.25, and 40.00 ± ± 4.12 for aloe gel, aloe gel and aloe leaf extract combined, and aloe leaf extract alone, respectively) was observed in animals in the aloe extract-and aloe gel-treated groups compared with 100% tumor incidence in the control group. The cumulative number of papillomas during an observation period of 16 weeks was significantly reduced in the aloe-treated groups (8.0 ± ± 0.34, 6.00 ± ± 1.10, and 9.00 ± ± 1.41 for aloe gel, aloe gel and leaf extract, and aloe leaf extract, respectively) compared with a 36 ± ± 0.98 cumulative number of papillomas in the control group. The average latent period was significantly increased from 4.9 ± ± 0.10 weeks in the control group to 6.37 ± ± 0.12, 6.8 ± ± 0.25, and 6.2 ± ± 0.21 weeks in the aloe-treated groups, respectively. The tumor burden and tumor yield were significantly decreased (2.0 ± ± 0.25, 2.00 ± ± 0.30, and 2.25 ± ± 0.2 and 0.8 ± ± 0.25, 0.6 ± ± 0.32, and 0.9 ± ± 0.28, respectively) as compared with the 7,12dimethylbenz(a)anthracene-treated control group (3.6 ± ± 0.10 and 3.6 ± ± 0.19). Furthermore, treatment with aloe gel and/or extract by topical and/or oral administration resulted in a significant increase in the reduced glutathione (P < < .05), DNA (P < < .001), catalase (P < < .05), and protein (P < < .001) in the skin of mice. Conversely, lipid peroxidation levels were significantly decreased (P < < .001) in the skin of mice.
Cell division is a normal process in multicellular organisms. If this process is rapid and uncontrolled, it may give rise to cancer. Normally, the division and growth of cells are orderly and controlled, but if this process becomes uncontrollable for some reason, then cells will continue to divide and develop into a tumor. Cancer claims more than 6 million lives each year on a worldwide basis and represents the single largest cause of death in both men and women. In recent years, there have been considerable efforts to find naturally occurring substances that can inhibit, reverse, or retard multistage carcinogenesis. Most human cancers appear to be caused by environmental factors. Populations differ greatly in the pattern of cancer incidence because of their dietary habits and environmental exposure. Nutritional and nonnutritional components in the diet seem to influence initiation and promotion of malignant growths. Results from various epidemiological studies indicate that 80% to 90% of all cancers that are caused by environmental factors and chemicals (natural or synthetic) are the prominent environmental carcinogens. 1 These chemical carcinogens, which are related to lifestyle, include those in tobacco smoke, 2 air, water, food, some drugs, and cosmetics. 3 There is a great possibility for exposure of human populations to various carcinogens in the present environment. Numerous naturally occurring chemopreventive agents modulate specific steps in the carcinogenic process, that is, block mutagenic carcinogens and prevent DNA damage by free radicals, suppress epithelial cell hyperproliferation, and/or modulate epithelial cell differentiation and apoptosis (programmed cell death). In recent years, there have been considerable efforts to find the naturally occurring substances that can inhibit or reverse multistage carcinogenesis. Wide arrays of substances present in the medicinal herbs or dietary plants have been screened for their ability to prevent carcinogenicity. A large number of medicinal or dietary plants have been shown to exhibit substantial inhibitory effects on experimentally induced carcinogenesis, and in many cases, their chemopreventive activities are associated with antioxidative and/or anti-inflammatory properties that some of these ingredients retain. 4 Aloe vera (L.) Burm.f. (synonym A. barbadensis Mill.) is commonly known as aloe vera. It belongs to the family Liliaceae. It is a popular household plant, found predominantly in dry localities in most parts of the world. A vera is a rosette of long, slender, thick, fleshy leaves, like a smooth rubbery cactus. The contents of a leaf can be separated into 2 basic components, gel and latex. Aloe gel contains glucomannan, acemannan, magnesium, glucose, γ-linolenic acid, saponins, sterols, calcium, and cholesterols, 5 while aloe latex (leaf lining) contains anthraquinone glycosides such as aloin, emodin, and barbaloin. 6 A vera has high concentrations of vitamins A, C, and E 7 ; zinc 8 ; and amino acids, which are responsible for its usefulness in various pathological conditions. The acemannan of aloe has been used for topical treatment of wounds, minor burns, and skin irritation. Its juice is commonly used on burns and minor cuts for enhancing the healing of dermal wounds. 9 Some recent studies have demonstrated direct inhibitory effects of aloe extract and aloe gel on both tumor initiation and promotion. A polysaccharide fraction of aloe gel and aloe extract inhibited the binding of benzopyrene to primary rat hepatocytes and thus prevented the formation of potential cancer-initiating benzopyrene DNA adducts. 10 In another study, aloe gel caused an induction of glutathione-S-transferase and inhibition of tumorpromoting effects of phorbol myristic acetate. 11 These studies suggest a possible benefit of using aloe gel and aloe extract in cancer chemoprevention. The present study evaluates the chemopreventive effect of the plant extract of A vera after topical application and/or oral administration against 7,12-dimethylbenz(a)anthracene DMBA)/ croton oil-induced skin papillomagenesis in mice.
Materials and Methods
The animal care and handling was approved by our institution and was done according to guidelines set by the World Health Organization, Geneva, Switzerland, and the Indian National Science Academy, New Delhi, India. The inhibition of tumor incidence by A vera leaf extract was evaluated on 2-stage skin carcinogenesis, induced by a single application of DMBA (initiator) and, 2 weeks later, promoted by repeated application of croton oil (promoter) thrice per week, following the protocol for 16 weeks.
Animals
The study was conducted on random-breed male Swiss albino mice (7-8 weeks old), weighing 24 ± 2 g. These animals were housed in polypropylene cages in the animal house under controlled conditions of temperature (25°C ± 2°C) and light (14 light:10 dark). The animals were fed a standard mouse feed procured from Aashirwad Industries, Chandigarh (India), and water ad libitum. Four animals were housed in 1 polypropylene plastic cage containing saw dust (procured locally) as bedding material. As a precaution against infections, tetracycline hydrochloride water was given to these animals once each fortnight. Three days before the commencement of the experiment, hair on the interscapular region of the mice was clipped. Only those animals in the resting phase of the hair cycle, showing no hair growth, were used for the study.
Chemicals
The initiator DMBA and croton oil (used as promoter) were procured from Sigma Chemical Co (St Louis, MO). DMBA was dissolved at a concentration of 100 µg/100 µL in acetone. Croton oil was mixed in acetone to give a solution of 1% dilution.
Preparation of A vera Extract
Plant material (A vera leaves) was collected locally after its proper identification by a competent botanist from the Herbarium, Department of Botany, University of Rajasthan, Jaipur, voucher no. RUBL 19886. Mature leaves of the plant were washed, shade dried, and powdered and mixed with double the volume of absolute ethyl alcohol. The mixture was stirred and left for 24 hours, after which it was filtered and again mixed with the same volume of ethyl alcohol as used earlier.
The procedure was repeated twice. Finally, all 3 filtrates were mixed, and the alcohol was allowed to evaporate naturally at room temperature (30°C ± 3°C) to obtain a concentrated aloe extract (0.8%). The powdered extract, termed A vera extract (AVE), was redissolved in double distilled water (DDW) just before oral administration. The required dose for treatment was prepared by dissolving the extract in DDW at a dose level of 1000 mg/kg body weight. The aloe gel is prepared by peeling off the green layer of the fresh, fleshy leaves; the transparent pulp was homogenized and passed through cheesecloth. The resulting pulp extract was stored at 4°C and used for treating animals.
Experimental Design
A total of 60 animals were randomly divided into the following 6 groups to evaluate the anticarcinogenic potential of AVE and aloe gel against DMBA-induced skin papillomagenesis in mice.
Normal (DDW treated). Animals were put on a normal diet and treated with DDW by oral gavage daily for 15 days.
Drug alone (AVE treated). Animals were put on a normal diet and treated with AVE 1000 mg/kg/d for 15 days.
Group 1.
A control group of 10 animals were treated with a single dose of DMBA (100 µg/100 µL of acetone) over the shaven area of the skin of the mice. Two weeks later, croton oil (1% in 100 µL of acetone) was applied as a promoter 3 times per week until the end of the experiment (ie, 16 weeks).
Group 2.
A group of 10 animals were treated with aloe gel (1 mL/9 cm²) topically 30 minutes after DMBA (100 µg/100 µL of acetone) application, followed by the application of croton oil (1% in 100 µL of acetone thrice a week) until the end of the experiment (ie, 16 weeks).
Group 3.
A group of 10 animals were treated with AVE (1000 mg/kg body weight) oral treatment starting with DMBA (100 µg/100 µL of acetone) followed by the application of croton oil (1% in 100 µL of acetone thrice a week) until the end of the experiment (ie, 16 weeks).
Group 4.
A group of 10 animals were treated with aloe gel (1 mL/9 cm²) topical as well as oral AVE (1000 mg/kg body weight) starting (100 µg/100 µL of acetone) treatment followed by the application of croton oil (1% in 100 µL of acetone thrice a week) until the end of the experiment (ie, 16 weeks).
During the 16 weeks of experimentation, mice were observed daily and weighed weekly. The mice were carefully examined once per week for the presence of skin papillomas, and these were recorded.
The following parameters were taken into consideration:
Tumor incidence: The number of mice carrying at least 1 tumor, expressed as a percentage incidence. Tumor yield: The average number of papillomas per mouse. Tumor burden: The average number of tumors per tumorbearing mouse. Diameter: The diameter of each tumor was measured. Weight: The weight of the tumors of each animal at the termination of each experiment was measured. Body weight: The weight of the mice was measured weekly. Average latent period: The lag between the application of the promoting agent and the appearance of 50% of tumors was determined. The average latent period was calculated by multiplying the number of tumors appearing each week by the time in weeks after the application of the promoting agent and dividing the sum by total number of tumors.
Average latent period =
∑ fx n where f is the number of tumors appearing each week, x is the numbers of weeks, and n is the total number of tumors.
Biochemical Study
Biochemical alterations were studied in animals of all groups at the time of the termination of the experiment (ie, the 16th week). At the end of the 16th week, the animals were killed by cervical dislocation. The dorsal skin affected by tumors was quickly excised and washed thoroughly with chilled saline (pH 7.4). It was then weighed and blotted dry. A 10% tissue homogenate was prepared from part of the sample (skin) in 0.15 M Tris-KCL (pH 7.4), and the homogenate was then centrifuged at 12000 rpm for 15 minutes. The supernatant thus obtained was taken for estimation of catalase, reduced glutathione (GSH), lipid peroxidation (LPO), DNA, and protein.
LPO Estimation
The level of LPO was estimated using the method of Ohkawa. 12 Briefly, thiobarbituric acid (0.8%), sodium dodesyl sulphate (0.1%), and acetic acid (20%) were added to 100 µL of the tissue homogenate 10% prepared as described above. This mixture was heated for 60 minutes, cooled, and extracted with Nbutanol-pyridine, and the optical density (OD) of LPO was recorded at 532 nm. The content of LPO is expressed as nmol/mg of protein.
GSH Estimation
The level of GSH was estimated by the method of Moron et al. 13 The proteins were precipitated in the 12 000 rpm supernatant (obtained as described above) by the addition of trichloroacetic acid (TCA), to a final concentration of 5% TCA. This was then centrifuged at 15 000 rpm for 15 minutes to obtain the protein-free supernatant. To 100 µL of this supernatant, 2 mL of 0.6 M 5, 5′ dithio-bis (2-nitrobenzoic acid) dissolved in 0.2 M phosphate buffer (pH 8) was added. The absorbance was recorded at 412 nm. Reduced GSH was used as a standard. The levels of GSH are expressed as nmol/mg of protein.
Catalase Assay
The catalase was assayed by the method of Aebi. 14 The change in absorbance was followed spectrophotometrically at 240 nm after the addition of H 2 O 2 (30 mM) to 100 µL of the supernatant (10% of the tissue obtained as described above) in 50 mM phosphate buffer (pH 7).The activity of the enzyme is expressed as µmol of H 2 O 2 reduced/mg protein/min.
Protein Estimation
Protein estimation was determined by the method of Bradford 15 using bovine serum album as a standard.
DNA Estimation
DNA was estimated by the Burton method. 16 Homogenate was centrifuged at 10 000 rpm for 10 minutes and washed with 5 mL cold 10% TCA. Thereafter, the homogenate was kept for 30 minutes at 4°C and centrifuged at 10 000 rpm for 10 minutes. The pellet was collected and mixed with 5 mL cold 10% TCA. The mixture was centrifuged at 10 000 rpm for 10 minutes and further mixed with 5 mL alcohol ether (3:1) and centrifuged at 10 000 rpm for 10 minutes. The pellet was collected and mixed with 5 mL 1N KOH and incubated for 16 to 18 hours at 37°C. The solution was mixed with 0.4 mL of 6N HCL and 5 mL of cold 5% TCA and allowed to precipitate at 4°C for 30 minutes, then centrifuged at 10 000 rpm for 10 minutes. The pellet was collected and mixed with 5 mL 5% TCA, heated for 15 minutes at 90°C, and cooled under tap water. Again, it was centrifuged at 10 000 rpm for 10 minutes, and the supernatant was collected. The 1 mL of supernatant was mixed with 2 mL diphenyl reagent and incubated for 16 to 18 hours at 37°C, and the OD of the DNA was recorded at 620 nm after setting zero with blank. The levels of DNA were expressed as mg/g of tissue sample.
Statistical Analysis
The results are expressed as the mean ± standard error of the mean or as a percentage. The data from biochemical determinations were analyzed using the Student t test.
Results
The findings of the present study are depicted in Table  1 and Figures 1 through 9 . Animals from group 1 (control), in which a single topical application of DMBA was followed by croton oil, produced skin papillomas, which started appearing from the sixth week onward. The tumor incidence in the DMBA/croton oil-treated mice (carcinogen control) reached 100% by the end of the experiment (16 weeks). The cumulative number of papillomas in these mice was recorded as 36. The average number of papillomas per mouse (tumor yield) as well as the papillomas per papilloma-bearing mice (tumor burden) was found to be 3.6. These were significantly reduced in all experimental groups (groups 1, 3, and 4). The average latency period (ie, time lag between the application of the promoter and the appearance of 50% of tumors) was also greater with aloe vera gel and/or extract by topical and/or oral administration.
Significantly lower glutathione peroxide (GSH), DNA, catalase, and protein activity was noted in the skin in the carcinogen control mice (group 1) as compared with aloe extract-treated experimental animals (groups 2, 3, and 4) at the time of termination of the experiment (ie, 16 weeks). Treatment with AVE resulted in enhanced levels of GSH (P < .05), DNA (P < .001), catalase (P < .05), and protein (P < .001) in these groups. A considerable elevation of LPO level was noted in the skin after DMBA and croton oil treatment, whereas administration of A vera (P < .001) significantly reduced the level of LPO in all the aloe extract-treated experimental groups (2, 3, and 4) in comparison with the carcinogen control group.
Discussion
Epidemiological evidence suggests that a diet high in fruits and vegetables is associated with a decrease in the incidence of cancer and cardiovascular disease and possibly of other degenerative or age-related diseases. 17 Much progress in the understanding of functional relationships between nutritional factors has been provided by epidemiological and diet intervention studies 18 and relevant in vivo studies of progression and inhibition. This concept is based on the mechanism of action of the chemical compounds and/or micronutrients in foods and their toxicity and chemopreventive efficacy. 19 The skin carcinogenesis model in experimental animals has been found to be a very useful system for investigating the influence of dietary chemopreventors both mechanistically and operationally. 20 The present study demonstrated that oral administration of the AVE (1000 mg/kg body weight) at the peri-initiation phase showed a significant reduction in tumor incidence, tumor burden, tumor weight, tumor size, cumulative number of papillomas, and LPO levels, with a significant increase in the average latent period of tumor appearance, GSH, protein, DNA, and catalase activity observed in aloe-treated groups relative to the carcinogentreated control.
Significant effects were achieved, implying that the plant extract may have either inhibited the metabolism of DMBA to its active form, delayed the promotion phase of carcinogenesis, or downregulated reactive oxygen species formation. Such depletion of tumorigenesis owing to similar factors and in various plants has been reported by others. [21] [22] [23] Some recent studies have demonstrated direct inhibitory effects of aloe gel on both tumor initiation and promotion. A polysaccharide fraction of aloe gel inhibited the binding of benzopyrene to primary rat hepatocytes and thus prevented the formation of potential cancer-initiating benzopyrene adducts. 10 A follow-up study published by the same investigators showed that several other plant-derived polysaccharides were also able to block benzopyrene DNA adducts. 11 Chemoprevention is currently an important strategy for controlling the process of cancer induction. Therefore, there is a need to explore medicinal plants or other natural agents that can work as chemopreventive agents. The present study demonstrates the chemopreventive potential of AVE and gel on DMBA-induced skin tumorigensis in male Swiss albino mice. The literature suggests that 1 subminimal dose of carcinogen initiates the process of carcinogenesis, and the treatment with croton oil promotes this process to a visible tumor stage. 24 The present investigation exhibited this process with 100% tumor incidence and a tumor yield as well as tumor burden of 3.6 in group 1 (control) animals. Evidence has accumulated to suggest that this is perhaps due to reactive oxygen species, which play an important role in tumor initiation by enhancing or facilitating the metabolic activation and/or initiating effects of carcinogens. 25 Reactive oxygen and/or nitrogen oxide species-induced stress (RONOSS) and its downstream events are clearly important for carcinogenesis. RONOSS can be induced by exposure to carcinogenic xenobiotics and microorganisms, 26 and the various cellular alterations induced by RONOSS play a crucial role in carcinogenesis. 27 Antioxidants are expected to inhibit RONOSS because of an alteration in relevant enzyme profiles and quenching. 28, 29 A vera, used in the tumor study, is a well-known natural substance. It is a source of polysaccharides, selenium, calcium, copper, zinc, chromium, and vitamins A, E, and C, and it has been found to have anti-inflammation, wound-healing, antihepatitis, antigastric ulcer, antineoplastic, anti-initiating, and antipromoting properties. Polysaccharides are given to cancer patients because of their direct toxic effects on cancer cells and indirect improvements on the immune system. GSH is a major antioxidant that is found in large amounts in all cells. GSH has many functions in metabolism, free radical scavenging, and regeneration of other antioxidants such as vitamin E. The most important function of GSH is to provide protection against oxidative damage induced by reactive oxygen species, many of which are generated during normal cellular metabolic processes. 30 The properties of A vera as an antioxidant, as well as an antioxidant enzyme system stimulant, lead to the supposition that it has played a role in augmenting the activity of antioxidant enzymes such as catalase, GSH, and superoxide dismutase, concomitant with a reduction in LPO.
Experimental studies have demonstrated that vitamin C (ascorbic acid) can inhibit the formation of nitroso compounds both in vivo and in vitro. 31 The term retinoid includes all natural and synthetic analogues of vitamin A. It has been found that most primary human cancers arise in epithelial tissues, which depend on retinoids for normal cellular differentiation. 32, 33 Together with the retinoids, the selenium salts have been studied extensively as suppressing agents in experimental neoplastic systems. Selenium can inhibit both the initiation and promotion phases of carcinogensis; a continuous intake of selenium is necessary to achieve a maximal inhibition of tumorigensis. 34 From the present study, it has been found that the Indian plant A vera is a source of many anticarcinogenic agents and antioxidants, which may be useful for the prevention of cancer. The present work suggests further evaluation of the efficacy of this well-known plant. 
